Cycloheximide inhibits cellular, but not SV40, DNA replication.
We have prepared extracts from cycloheximide-treated cells for the study of simian-virus-40 (SV40)-DNA replication in vitro. When supplemented with the viral initiator protein (large T antigen), these extracts fully supported SV40-DNA replication. We also determined that SV40-DNA replication in vivo is much more resistant to cycloheximide than cellular DNA replication. SV40 encodes its own initiator protein, T antigen, which also functions as a DNA helicase, but depends on cellular functions for all additional replication reactions. Therefore, it appears to be quite likely that cycloheximide affects cellular DNA replication by blocking the synthesis of (a) cellular function(s) that is(are) performed by T antigen in SV40-DNA replication. Indeed, DNA fiber autoradiography and alkaline sucrose gradient centrifugation of pulse-labeled cellular DNA showed that cycloheximide treatment almost completely suppressed replicon initiation and reduced the rate of replication fork movement to about one third of the control.
Schulte
D
D
Fakultät für Biologie, Universität Konstanz, Germany.
Knippers
R
R
Dreier
T
T
Probst
G
G
Probst
H
H
D000952:Antigens, Polyomavirus Transforming / Q000032:analysis; D001345:Autoradiography; D003513:Cycloheximide / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects*; D004279:DNA, Viral / Q000187:drug effects*; D006367:HeLa Cells; D006801:Humans; D013539:Simian virus 40 / Q000276:immunology / Q000378:metabolism*
D000952:Antigens, Polyomavirus Transforming; D004279:DNA, Viral; D003513:Cycloheximide